Last 19 quarters of trend data · Technology · Consumer Electronics
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.97 | — | — | — | — | — | — | — | — | 17.97 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 11.63 | 0.08 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| — | +468.7% | -25.0% | -26.0% | -32.9% | +94.5% | +26.7% | +85.0% | +68.4% | +81.6% | -48.6% | -69.0% | -77.5% | |
| P/B Ratio | 0.29 | 0.11 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| — | +1315.1% | +57.7% | +3.0% | -33.5% | +9.3% | -40.1% | -12.9% | +2.3% | -3.0% | -75.7% | -89.0% | -89.4% | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | 49.94 | — | — | — | — | — | — | 12.15 | 7.79 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | 28.91 | 7.79 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
Zepp Health Corporation's operating margin was -1.2% in Q3 2025, up 9.1 pp QoQ and up 28.4 pp YoY. This marks the 3rd consecutive quarter of margin expansion, signaling a sustained improvement in operating efficiency. The trailing four-quarter average of -18.5% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 6.0% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 38.5% | 38.2% | 36.2% | 37.3% | 36.8% | 40.6% | 40.3% | 36.8% | 34.7% | 33.9% | 22.0% | 15.9% | 20.7% |
| — | -6.0% | -10.1% | +1.3% | +6.0% | +19.8% | +83.1% | +130.8% | +67.8% | +77.2% | +13.9% | -16.1% | +0.6% | |
| Operating Margin | -25.9% | -1.2% | -10.3% | -47.7% | -15.0% | -29.5% | -24.3% | -39.8% | 0.8% | 1.8% | -11.2% | -23.4% | -6.6% |
| — | +96.0% | +57.7% | -19.7% | -2090.4% | -1739.8% | -117.4% | -70.2% | +111.4% | +129.6% | -1942.7% | -824.2% | -283.6% | |
| Net Margin | -41.6% | -2.1% | -13.0% | -51.2% | -62.0% | -31.2% | -26.7% | -37.0% | -1.5% | 0.5% | -10.8% | -21.2% | -7.0% |
| — | +93.2% | +51.1% | -38.6% | -3925.0% | -6415.9% | -147.2% | -74.4% | +78.1% | +134.9% | -593.6% | -462.8% | -294.3% |
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -25.5% | -0.7% | -3.4% | -8.1% | -13.2% | -4.1% | -3.3% | -4.3% | -0.4% | 0.1% | -2.8% | -5.3% | -2.7% |
| — | +82.5% | -2.1% | -87.1% | -3553.4% | -3530.6% | -16.0% | +17.8% | +86.4% | +119.1% | -322.7% | -224.9% | -187.0% | |
| ROA | -13.3% | -0.3% | -1.4% | -3.8% | -6.7% | -2.2% | -1.9% | -2.5% | -0.2% | 0.1% | -1.5% | -2.7% | -1.3% |
| — | +87.3% | +22.8% | -53.5% | -3340.3% | -3730.1% | -27.4% | +10.0% | +85.1% | +120.6% | -343.3% | -247.7% | -195.9% | |
| ROIC | -9.8% | -0.2% | -1.4% | -4.3% | -1.9% | -2.4% | -1.9% | -3.0% | 0.1% | 0.3% | -1.8% | -3.5% | -1.5% |
| — | +90.9% | +26.4% | -41.6% | -1791.2% | -985.9% | -7.2% | +12.3% | +107.6% | +114.7% | -559.5% | -181.9% | -124.2% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
Zepp Health Corporation's Debt/EBITDA ratio is 297.8x — elevated, raising questions about debt serviceability. The current ratio has weakened 10.0% YoY to 1.09x, tightening the short-term liquidity position.
| Metric | TTM | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.72 | 0.49 | 0.86 | 0.80 | 0.72 | 0.63 | 0.57 | 0.54 | 0.55 | 0.57 | 0.62 | 0.63 | 0.64 |
| — | -22.4% | +49.9% | +47.4% | +29.9% | +10.3% | -8.3% | -13.7% | -13.7% | -6.8% | +45.5% | +152.5% | +70.6% | |
| Debt / EBITDA | — | 297.77 | — | — | — | — | — | — | 163.12 | 93.56 | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.29 | 1.09 | 1.10 | 1.14 | 1.29 | 1.21 | 1.39 | 1.71 | 2.04 | 2.05 | 1.92 | 2.16 | 1.77 |
| — | -10.0% | -20.8% | -33.4% | -36.9% | -40.8% | -27.9% | -20.5% | +15.2% | +24.2% | +5.3% | +24.5% | +10.8% | |
| Quick Ratio | 1.00 | 0.78 | 0.78 | 0.84 | 1.00 | 0.87 | 1.02 | 1.26 | 1.49 | 1.40 | 1.38 | 1.49 | 1.16 |
| — | -10.2% | -23.7% | -33.3% | -33.3% | -37.9% | -26.1% | -15.5% | +28.9% | +41.5% | +10.4% | +15.2% | -9.2% | |
| Interest Coverage | -8.51 | -0.77 | -4.90 | -13.53 | -6.18 | -9.73 | -7.18 | -11.03 | 0.44 | 0.93 | -5.88 | -11.33 | -4.40 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 19 years · Updated daily
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationCompare performance and metrics against top competitors.
Start ComparisonZepp Health Corporation's current P/E is -1.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Zepp Health Corporation's current operating margin is -25.9%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Zepp Health Corporation's business trajectory between earnings reports.